ATE193441T1 - Behandlung von migräne - Google Patents

Behandlung von migräne

Info

Publication number
ATE193441T1
ATE193441T1 AT93907357T AT93907357T ATE193441T1 AT E193441 T1 ATE193441 T1 AT E193441T1 AT 93907357 T AT93907357 T AT 93907357T AT 93907357 T AT93907357 T AT 93907357T AT E193441 T1 ATE193441 T1 AT E193441T1
Authority
AT
Austria
Prior art keywords
blocking agent
migraines
treatment
administered
relates
Prior art date
Application number
AT93907357T
Other languages
English (en)
Inventor
Arthur M Goldberg
Leonard Lachman
Original Assignee
Ribogene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribogene Inc filed Critical Ribogene Inc
Application granted granted Critical
Publication of ATE193441T1 publication Critical patent/ATE193441T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Disintegrating Or Milling (AREA)
AT93907357T 1992-03-13 1993-03-08 Behandlung von migräne ATE193441T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/850,566 US5242949A (en) 1992-03-13 1992-03-13 Treating classic migraine
PCT/US1993/002132 WO1993017672A1 (en) 1992-03-13 1993-03-08 Treatment of migraine

Publications (1)

Publication Number Publication Date
ATE193441T1 true ATE193441T1 (de) 2000-06-15

Family

ID=25308498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93907357T ATE193441T1 (de) 1992-03-13 1993-03-08 Behandlung von migräne

Country Status (18)

Country Link
US (1) US5242949A (de)
EP (1) EP0727986B1 (de)
JP (1) JP2839207B2 (de)
KR (1) KR950701215A (de)
AT (1) ATE193441T1 (de)
AU (1) AU675931B2 (de)
CA (1) CA2131991C (de)
DE (1) DE69328792T2 (de)
DK (1) DK0727986T3 (de)
ES (1) ES2148222T3 (de)
FI (1) FI944236A7 (de)
GR (1) GR3034188T3 (de)
HU (1) HUT71834A (de)
MX (1) MX9301393A (de)
NO (1) NO943372L (de)
PH (1) PH30101A (de)
PT (1) PT727986E (de)
WO (1) WO1993017672A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408026A (en) * 1993-08-23 1995-04-18 Cowan; Patrick J. Curable and cured organosilicon compositions, and process for making same
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
WO2008097664A1 (en) 2007-02-11 2008-08-14 Map Pharmaceuticals, Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US20080226715A1 (en) * 2007-03-16 2008-09-18 Albert Cha Therapeutic compositions and methods
WO2009103150A1 (en) * 2008-02-20 2009-08-27 Kevin David Smith Method for treating migraine headaches
WO2013016223A2 (en) 2011-07-22 2013-01-31 The University Of Chicago Treatments for migraine and related disorders
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394390A (en) * 1979-08-03 1983-07-19 University Of Kentucky Research Foundation Nasal dosage forms of propranol
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same

Also Published As

Publication number Publication date
JPH08500329A (ja) 1996-01-16
FI944236A0 (fi) 1994-09-13
FI944236L (fi) 1994-11-11
GR3034188T3 (en) 2000-11-30
WO1993017672A1 (en) 1993-09-16
JP2839207B2 (ja) 1998-12-16
EP0727986A4 (de) 1995-04-25
PH30101A (en) 1996-12-27
DE69328792D1 (de) 2000-07-06
AU3799193A (en) 1993-10-05
EP0727986A1 (de) 1996-08-28
MX9301393A (es) 1994-08-31
NO943372D0 (no) 1994-09-12
HU9402612D0 (en) 1994-11-28
KR950701215A (ko) 1995-03-23
PT727986E (pt) 2000-11-30
CA2131991A1 (en) 1993-09-16
CA2131991C (en) 1999-07-06
DK0727986T3 (da) 2000-10-30
ES2148222T3 (es) 2000-10-16
FI944236A7 (fi) 1994-11-11
HUT71834A (en) 1996-02-28
AU675931B2 (en) 1997-02-27
NO943372L (no) 1994-11-14
EP0727986B1 (de) 2000-05-31
US5242949A (en) 1993-09-07
DE69328792T2 (de) 2001-02-01

Similar Documents

Publication Publication Date Title
TW200607512A (en) Use of optically pure (S,S)-reboxetine in the manufacture of a medicament for the treatment or prevention of migraine headaches
NZ285159A (en) Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
NO961478L (no) Levobupivacaine anvendelig for kontroll av kronisk smerte
ATE359074T1 (de) Raloxifene in der behandlung von postmeopausal osteoporose
NO941065D0 (no) Fremgangsmåte og blandinger for behandling av cerebral lammelse
ATE144898T1 (de) Behandlung neurodegenerativer krankheiten
ATE193441T1 (de) Behandlung von migräne
DK71387A (da) Terapeutisk middel til behandling af psoriasis
SE9601395D0 (sv) New therapeutic treatment 1
ATE293972T1 (de) Behandlung von chronischen schmerzen
NO962221L (no) Anvendelse av dimeticon for behandling av konstipasjon
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
DE60024408D1 (de) Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
NO984190L (no) FremgangsmÕte for behandling av insomnia
PT1304107E (pt) Utilizacao de derivados de oxazolidininas para o tratamento da psoriase
RU96114051A (ru) Способ лечения экземы у травматолого-ортопедических больных с гнойной инфекцией
UA50329A (uk) Спосіб лікування первинної бешихи
UA31156A (uk) Спосіб лікування пневмоентеритів телят
RU96122672A (ru) Эхинамакс. способ лечения астенических состояний при физиогенных дезадаптациях

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee